LUC7L3 and nasopharyngeal carcinoma: Microarray analysis was used to evaluate the blood-based gene expression signature and identified three genes, LDLRAP1, PHF20, and LUC7L3, that could differentiate NPC from controls and patients affected by other diseases [118].